Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00819507 · ClinicalTrials.gov registry record · Phase 4
VANOS Cream and Skin Barrier Function
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT00819507 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 25 participants.
The verdict
NCT00819507, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of short-term therapy using "VANOS Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic dermatitis. This cream is already approved for this indication, but the investigators will further examine its effects on the skin barrier. This cream is a novel formulation of fluocinonide designed to enhance compliance with a cream base, but have the skin barrier repair properties of an ointment.
Interventions
- DRUG Fluocinonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-06-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00819507
The ClinicalTrials.gov registry entry for NCT00819507 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluocinonide is the first listed.
NCT00819507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00819507 about?
NCT00819507 is a clinical study titled "VANOS Cream and Skin Barrier Function". The purpose of this study is to determine the effect of short-term therapy using "VANOS Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic dermatitis. This cream is already approved for this indication, but the investigators will further examine its effects...
What is the current status of trial NCT00819507?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2009-01. Estimated completion is 2010-06-21.
What interventions are being tested in trial NCT00819507?
The interventions under investigation include: Fluocinonide (DRUG).
Who is sponsoring clinical trial NCT00819507?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.